Search Results
Search results for "new jersey"
249 results found for "new jersey"
- Beyond Medication: Tech Advances in Care Delivery
, and ensure our technology reflects our values as communities, not just that of those who may find new
- COST CONTAINMENT vs. CARE EQUALITY
Available from https://www.axa.com/en/news/women-vs-men-is-there-a-health-equality-gap [3] U.S.
- Biden's State of the Union: Bold Promises on Public Health
Public health professionals who have long advocated for more robust responses to the pandemic took to news
- Jen's Half Cents: Attacks on Abortion and Trans Care are Attacks on Medication Access
important note: most abortions in the United States are medication abortions, not surgical.If you’re new
- HIV Advocates Gather in Nashville for Health Fireside Chat
Association plans to host additional Health Fireside Chats later this year in Philadelphia, PA, and New
- Lived Values: Trans Employment Survey of National HIV Advocacy Organizations
In many states, this is no new battle.
- The Future of Prescription Drug Affordability Boards and Upper Payment Limits Is Cloudy
A January 2025 New York Times article also explains the unintended harms of the Inflation Reduction Act
- Jen's Half Cents: Employers' Role In Ending the HIV Epidemic, Addressing Health Equity, and Retaining Talent
Often referred to in news media as “The Great Resignation”, it is a backdrop that also includes labor
- The Recipe for Change: From Surviving Appointments to Changing Policy
One workshop creates ten new advocates who now know how to speak to their own legislators.
- DEA Proposed Rules Risk Harming Access to Care
Orion Rummler of 19th News recently asked for an update and will be following up on the status of a response
- Jen's Half Cents: Fixing the Broken Patient Advocacy Pipeline
years and years, with limited power of influence over industry activities, and zero incentive to seek new
- Importation Is Not a Fix. It Is a Symptom of a System Built to Shift Cost.
Under the new process, mailed drug shipments are screened by customs brokers against the FDA’s import



